DNA

Ginkgo Bioworks Holdings, Inc.

10.66

USD

+0.41

+4.00%

Sep 25, 15:59 UTC -4

Closed

After-Market

10.62

-0.04

-0.38%

Ginkgo Bioworks Holdings, Inc. Profile

About

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

Info & Links

CEO

Jason Kelly

Headquarters

27 DRYDOCK AVENUE, 8TH FLOOR
BOSTON, MA 02210, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

525

Employees

485

Ginkgo Bioworks Holdings, Inc. Statistics

Valuation Measures

Market Capitalization²

715.15M

Enterprise Value

630.62M

Enterprise Value/EBITDA(ttm)

-2.47

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.64

Price to Book(mrq)

1.42

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

74.21%

Operating Margin(ttm)

-260.22%

Profit Margin(ttm)

-253.36%

Return on Equity(ttm)

-60.27%

Return on Invested Capital(ttm)

-64.01%

Return on Assets(ttm)

-26.88%

Income Statement

Revenue(ttm)

132.42M

Revenue Per Share(ttm)

1.97

Gross Profit(ttm)

90.10M

EBITDA(ttm)³

-255.42M

Net Income Available to Common(ttm)

-290.80M

Diluted EPS(ttm)

-5.01

Share Statistics

Beta (5Y Monthly)

1.76

52-Week Change

-7.55%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

67.34M

Dividend Yield

0.00%

Float⁴

58.80M

% Held by Insiders

12.69%

% Held by Institutions

78.63%

Balance Sheet

Total Cash(mrq)

302.16M

Total Cash Per Share(mrq)

4.49

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.57%

Quick Ratio(mrq)

4.57%

Book Value Per Share(mrq)

6.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.46

Free Cash Flow(ytd)

-95.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DNA